Ischemix
www.ischemix.comIschemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems.
Read more
Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems.
Read more
Country
State
Massachusetts
Industry
Employees
1-10
Estimated Revenue
$5,000,000 to $10,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President , Research and Development
Email ****** @****.comPhone (***) ****-****President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Medical Officer
Email ****** @****.comPhone (***) ****-****Medical Director
Email ****** @****.comPhone (***) ****-****
Technologies
(5)
Reach decision makers at Ischemix
Free credits every month!
Ischemix FAQ
United States
Pharmaceutical Manufacturing
